Max Delbrück Center
Register
Register
Register

Nocturne GmbH

Medical Device Manufacturer

nocturne.one/Berlin, Germany
5 profile visits

About

Nocturne GmbH develops AI-powered retinal imaging biomarkers that enhance CNS drug development. Our device-agnostic platform standardizes OCT data quality and extracts advanced structural features linked to neuroinflammation, axonal loss, and neurodegeneration.

We help pharma improve trial enrichment, patient stratification, and early signal detection—either through analysis of existing datasets or integration into ongoing studies. Nocturne also co-develops exploratory and secondary imaging endpoints to support biomarker strategies in NMOSD, MS, and Alzheimer’s disease.

We welcome collaborations with companies aiming to accelerate development through reliable, scalable, and non-invasive retinal biomarkers.

Technology

Data science, AI / Machine learning

Disease Area

Inflammation / Autoimmune DiseasesNeurological Diseases

Biomedical Research, Medicine, Human Health

Biomarker DiscoveryTherapy Monitoring

Representatives

CEO

Nocturne GmbH